#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16270	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2216	730.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1557	1557	C	950	C	898	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16270	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2216	730.7	0	HET	.	.	.	T1412TGGGGG,TGGGGGG	.	1412	1412	T	1785	1785	T	898	TGGGGG,TGGGGGG	640,158	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16270	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2216	730.7	0	HET	.	.	.	C1525T	.	1525	1525	C	1898	1898	C	787	C,T	564,158	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29140	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3446	841.2	0	.	n	.	0	T695C	SNP	695	695	T	998	998	C	916	C	863	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29140	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3446	841.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	1941	1941	G	899	G,A,T	793,40,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29140	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3446	841.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2274	2274	C	880	C,T	811,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29140	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3446	841.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2348	2348	A	860	A	815	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29140	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3446	841.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2900	2900	C	910	C	867	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2262	folP	855	855	100.0	folP.l15.c4.ctg.1	1507	149.3	1	SNP	p	R229S	1	.	.	685	687	AGC	999	1001	AGC	228;223;224	A;G;C	223;219;215	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5798	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3358	172.0	1	SNP	p	S91F	1	.	.	271	273	TTC	575	577	TTC	219;214;214	T;T;C	197;193;194	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5798	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3358	172.0	1	SNP	p	D95G	1	.	.	283	285	GGC	587	589	GGC	216;216;216	G,C;G;C	199,1;197;195	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5798	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3358	172.0	1	SNP	p	G95N	0	.	.	283	285	GGC	587	589	GGC	216;216;216	G,C;G;C	199,1;197;195	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1730	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1269	135.3	0	.	p	.	0	F184L	NONSYN	550	552	TTC	831	833	TTG	182;184;187	T;T;G,C	172;175;160,13	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1730	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1269	135.3	1	SNP	p	G45D	0	.	.	133	135	GGC	414	416	GGC	193;190;192	G;G;C	183;180;182	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	836	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1101	75.7	0	.	n	.	0	A197.	DEL	197	197	A	677	677	A	190	A	175	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5828	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3004	193.3	1	SNP	p	D86N	0	.	.	256	258	GAC	575	577	GAC	236;237;229	G;A;C	211;210;210	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5828	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3004	193.3	1	SNP	p	R87W	0	.	.	259	261	CGT	578	580	CGT	227;227;228	C;G;T	209;209;206	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5828	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3004	193.3	1	SNP	p	S87R	1	.	.	259	261	CGT	578	580	CGT	227;227;228	C;G;T	209;209;206	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5828	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3004	193.3	1	SNP	p	R87I	0	.	.	259	261	CGT	578	580	CGT	227;227;228	C;G;T	209;209;206	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5828	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3004	193.3	1	SNP	p	S88P	0	.	.	262	264	TCC	581	583	TCC	228;234;232	T;C;C	208;211;210	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4804	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2818	169.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1634	1636	GGC	237;232;231	G;G;C	218;214;208	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4444	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2344	188.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1224	1226	GCA	241;244;240	G;C;A,G	234;234;231,1	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4444	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2344	188.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1227	1229	ATC	244;246;241	A;T;C	235;236;230	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4444	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2344	188.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1239	1241	GTG	240;238;238	G;T;G	226;222;221	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4444	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2344	188.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1239	1241	GTG	240;238;238	G;T;G	226;222;221	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4444	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2344	188.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1743	1745	ACC	214;217;213	A;C;C	189;195;199	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4444	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2344	188.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1797	1799	GCG	198;198;201	G;C;G	172;157;165	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4444	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2344	188.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1797	1799	GCG	198;198;201	G;C;G	172;157;165	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4444	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2344	188.2	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1920	1922	AGC	170;172;170	A,G;G;C,T	159,2;164;159,2	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4444	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2344	188.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1929	1931	GGC	166;165;166	G,A;G,T;C	155,2;157,1;155	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4444	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2344	188.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1947	1949	CCG	153;154;155	C,CGG;C,G;G	111,1;113,1;119	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6014	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3086	194.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1649	1651	CCG	238;239;240	C;C,T;G,A	211;216,2;215,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2452	porA	1146	1146	99.91	porA.l6.c30.ctg.1	1687	144.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	539	539	C	167	C	148	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3008	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1510	197.9	0	.	p	.	0	N38E	NONSYN	112	114	AAT	439	441	GAA	252;253;253	G;A;A	234;234;234	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3008	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1510	197.9	0	.	p	.	0	E48K	NONSYN	142	144	GAA	469	471	AAA	238;238;237	A,G;A,G;A	223,6;224,1;226	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3008	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1510	197.9	0	.	p	.	0	N134D	NONSYN	400	402	AAT	727	729	GAT	291;293;291	G,A;A;T	262,1;263;264	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3008	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1510	197.9	0	.	p	.	0	P175S	NONSYN	523	525	CCA	850	852	TCA	252;250;247	T;C;A	235;233;231	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3008	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1510	197.9	0	.	p	.	0	A218V	NONSYN	652	654	GCC	979	981	GTC	252;253;252	G;T;C	240;237;242	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3008	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1510	197.9	0	.	p	.	0	F222S	NONSYN	664	666	TTT	991	993	TCT	259;259;261	T;C,T;T	247;248,1;250	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3008	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1510	197.9	0	.	p	.	0	A259G	NONSYN	775	777	GCT	1102	1104	GGT	257;256;255	G,T;G,C;T,C	235,1;231,7;232,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3008	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1510	197.9	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1309	1311	GCA	240;243;246	G;C,A;A	226;226,1;231	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3008	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1510	197.9	1	SNP	p	G120K	1	.	.	358	360	AAG	685	687	AAG	259;259;261	A;A;G	242;242;242	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3008	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1510	197.9	1	SNP	p	A121D	1	.	.	361	363	GAC	688	690	GAC	262;260;263	G,A;A;C	239,2;241;242	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3008	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	1510	197.9	1	SNP	p	D121N	0	.	.	361	363	GAC	688	690	GAC	262;260;263	G,A;A;C	239,2;241;242	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11554	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4855	237.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1174	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1004	116.1	1	SNP	p	V57M	1	.	.	169	171	ATG	486	488	ATG	215;218;220	A;T;G	195;195;199	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
